Export 255 results:
[ Author
Filters: First Letter Of Last Name is C [Clear All Filters]
“Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.”, Ophthalmology, vol. 120, no. 8, pp. 1604-11.e4, 2013.
, , “Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.”, JAMA, vol. 314, no. 8, pp. 791-801, 2015.
, “A Novel and Efficient Site Selection Process for a Large Multi-Center Trial”, in 27th Annual Meeting for the Society for Clinical Trials, Orlando, FL, 2006.
, “Evaluation of the Age-Related Eye Disease Study Clinical Lens Grading System AREDS Report No. 31”, Ophthalmology, vol. 117, pp. 2112-2119.e3, 2010.
“Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.”, JAMA Ophthalmol, vol. 132, no. 3, pp. 272-7, 2014.
, “EFFECTIVENESS OF DIFFERENT MONITORING MODALITIES IN THE DETECTION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The Home Study, Report Number 3.”, Retina, vol. 36, no. 8, pp. 1542-7, 2016.
, “Summary results and recommendations from the age-related eye disease study.”, Arch Ophthalmol, vol. 127, no. 12, pp. 1678-9, 2009.
, “Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: Results From a Phase 1 Safety Trial”, Am J Ophthalmol, vol. 159, pp. 659-666.e1., 2015.
, “Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial.”, Am J Ophthalmol, vol. 159, no. 4, pp. 659-666.e1, 2015.
, “Experimental design issue for assessment of carotenoids lutein and zeaxanthin in age-related eye disease study 2 formulation for age-related macular degeneration--reply.”, JAMA Ophthalmol, vol. 132, no. 7, pp. 904-5, 2014.
, “Long-Term Effects of Vitamins C and E, β-Carotene, and Zinc on Age-Related Macular Degeneration: AREDS Report No. 35”, Opthalmology, vol. 120, pp. 1604-1611e.4, 2013.
, “Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31.”, Ophthalmology, vol. 117, no. 11, pp. 2112-9.e3, 2010.
, “No Clinically Significant Association Between CFH and ARMS2 Genotypes and Response to Nutritional Supplements: AREDS Report Number 38”, Ophthalmology, vol. 121, pp. 2173-2180, 2014.
, “The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study.”, Ophthalmology, vol. 110, no. 9, pp. 1683-9, 2003.
, “Ten-Year Follow-up of Age-Related Macular Degeneration in the Age-Related Eye Disease Study: AREDS Report No. 36”, JAMA Ophthalmol, vol. 132, pp. 272-277, 2014.
, “Preliminary assessment of celecoxib and microdiode pulse laser treatment of diabetic macular edema.”, Retina, vol. 30, no. 3, pp. 459-67, 2010.
, “Randomized Trial of the ForeseeHome Monitoring Device for Early Detection of Neovascular Age-Related Macular Degeneration. The HOme Monitoring of the Eye (HOME) Study Design - HOME Study Report Number 1”, Contemporary Clinical Trials, vol. 37, pp. 294-300, 2014.
, “Preliminary Assessment of Celecoxib and Microdiode Pulse Laser Treatment of Diabetic Macular Edema”, Retina, vol. 30, pp. 459-467, 2010.
“No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.”, Ophthalmology, vol. 121, no. 11, pp. 2173-80, 2014.
, “Serum Nutrient Levels as Risk Factors for Neovascular AMD”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2005.
, “Visual Acuity Loss Associated With Advanced AMD Fundus Lesions and With the Simplified AREDS AMD Severity Scale”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2007.
, “Experimental Design Issues for Assessment of Carotenoids Lutein and Zeaxanthin in Age-Related Eye Disease Study 2 Formulation for Age-Related Macular Degeneration”, JAMA Ophthalmol, vol. 132, pp. 904-905, 2014.
, “Association of Cognitive Function and Depression with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2 (AREDS2)”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2009.
, ,